Lois E. Top

740 total citations
9 papers, 583 citations indexed

About

Lois E. Top is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Lois E. Top has authored 9 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Ecology, Evolution, Behavior and Systematics and 3 papers in Agronomy and Crop Science. Recurrent topics in Lois E. Top's work include T-cell and Retrovirus Studies (7 papers), Vector-Borne Animal Diseases (5 papers) and Animal Disease Management and Epidemiology (3 papers). Lois E. Top is often cited by papers focused on T-cell and Retrovirus Studies (7 papers), Vector-Borne Animal Diseases (5 papers) and Animal Disease Management and Epidemiology (3 papers). Lois E. Top collaborates with scholars based in United States, Malaysia and Switzerland. Lois E. Top's co-authors include Sara Zaknoen, Claude Kasten-Sportès, Richard N. Bamford, Jeffrey D. White, Erich Roessler, Andrew Grant, Waldmann Ta, C K Goldman, Thomas A. Waldmann and V. Ellen Maher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Lois E. Top

9 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lois E. Top United States 8 434 180 176 140 116 9 583
Tatsuro Joh Japan 5 550 1.3× 295 1.6× 160 0.9× 220 1.6× 79 0.7× 9 725
S Konda Japan 8 275 0.6× 139 0.8× 123 0.7× 105 0.8× 29 0.3× 24 450
Kana Washio Japan 9 179 0.4× 113 0.6× 162 0.9× 133 0.9× 58 0.5× 44 555
Riko Kawano Japan 12 300 0.7× 98 0.5× 179 1.0× 85 0.6× 9 0.1× 18 523
Yoshimi Ueshima United States 12 323 0.7× 85 0.5× 168 1.0× 68 0.5× 17 0.1× 15 655
Gita Hariri United Kingdom 5 274 0.6× 20 0.1× 120 0.7× 18 0.1× 141 1.2× 5 555
Rick Sorensen United States 5 367 0.8× 24 0.1× 65 0.4× 23 0.2× 15 0.1× 8 472
E. M. van der Loo Netherlands 9 214 0.5× 15 0.1× 114 0.6× 15 0.1× 60 0.5× 13 472
Kohsuke Yanagisawa Japan 14 166 0.4× 20 0.1× 129 0.7× 25 0.2× 10 0.1× 29 520
Nobuaki Adachi Japan 10 96 0.2× 30 0.2× 105 0.6× 28 0.2× 7 0.1× 20 574

Countries citing papers authored by Lois E. Top

Since Specialization
Citations

This map shows the geographic impact of Lois E. Top's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lois E. Top with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lois E. Top more than expected).

Fields of papers citing papers by Lois E. Top

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lois E. Top. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lois E. Top. The network helps show where Lois E. Top may publish in the future.

Co-authorship network of co-authors of Lois E. Top

This figure shows the co-authorship network connecting the top 25 collaborators of Lois E. Top. A scholar is included among the top collaborators of Lois E. Top based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lois E. Top. Lois E. Top is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Carbone, David P., I. Frank Ciernik, Michael J. Kelley, et al.. (2005). Immunization With Mutantp53- andK-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome. Journal of Clinical Oncology. 23(22). 5099–5107. 127 indexed citations
2.
Morris, John C., John E. Janik, Jeffrey D. White, et al.. (2005). Preclinical and phase I clinical trial of blockade of IL-15 using Mikβ1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proceedings of the National Academy of Sciences. 103(2). 401–406. 51 indexed citations
3.
White, Jeffrey D., Gilian Wharfe, Donn M. Stewart, et al.. (2001). The Combination of Zidovudine and Interferon AIpha-2B in the Treatment of Adult T-Cell Leukemia/Lymphoma. Leukemia & lymphoma. 40(3-4). 287–294. 55 indexed citations
4.
Carrasquillo, Jorge A., Jeffrey D. White, Chang H. Paik, et al.. (1999). Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.. PubMed. 40(2). 268–76. 72 indexed citations
5.
Lehky, Tanya, Michael C. Levin, Ryuji Kubota, et al.. (1998). Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti‐tac. Annals of Neurology. 44(6). 942–947. 59 indexed citations
6.
White, Jeffrey D., Sara Zaknoen, Claude Kasten-Sportès, et al.. (1995). Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia/lymphoma. Cancer. 75(7). 1598–1607. 29 indexed citations
7.
Ta, Waldmann, C K Goldman, Lois E. Top, et al.. (1993). The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood. 82(6). 1701–1712. 7 indexed citations
8.
Ta, Waldmann, C K Goldman, Lois E. Top, et al.. (1993). The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. Blood. 82(6). 1701–1712. 177 indexed citations
9.
Waldmann, Thomas A., Carolyn K. Goldman, Lois E. Top, et al.. (1992). The Interleukin-2 Receptor: A Target for Immunotherapy. Advances in experimental medicine and biology. 323. 57–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026